DoD Tuberous Sclerosis Complex Research Program
Clinical Translation Research Award
Amount of funding: Direct costs budgeted will not exceed $750,000.
Purpose: The Clinical Translational Research Award supports studies that will move promising, wellfounded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis, or treatment of TSC. Projects supported by this award mechanism may include, but not limited to: 1)Studies moving from preclinical to clinical research and/or the reverse, analyzing human anatomical substances and/or data associated with completed clinical trials (such as correlative studies), 2) Studies advancing clinical trial readiness through development of biomarkers, clinical endpoints, and validation of pharmacokinetics/pharmacodynamics (PK/PD), or 3)Pilot clinical trials, including behavioral interventions.
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI.
Not eligible: Stanford Instructors, Clinical Instructors, Academic Staff-research, and Postdocs are not eligible because Stanford does not consider them to be independent or faculty level positions.
Pre-application/Letter of intent (required) deadline: June 17, 2021 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) deadline: June 30, 2021
Full proposal deadline: July 8, 2021 via grants.gov